Clinical Validation of The Combei BP 880 W
Clinical Validation of the Wrist Blood Pressure Measuring Device Combei BP 880 W for Home Use According to "the Universal" Standard (AAMI/ESH/ISO)" in the General Population
1 other identifier
interventional
85
1 country
1
Brief Summary
Clinical validation of the wrist blood pressure measuring device Combei BP 880 W for home use according to "the Universal Standard for the validation of blood pressure measuring devices by the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO)" in the general population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hypertension
Started Jan 2023
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 31, 2022
CompletedStudy Start
First participant enrolled
January 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 23, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 27, 2023
CompletedFirst Posted
Study publicly available on registry
June 1, 2023
CompletedJune 1, 2023
May 1, 2023
4 months
May 31, 2022
May 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy of blood pressure measurement
differences \< than 5 +/- 8 mmHg according to the protocol by comparison to the gold standard (mercury sphygmomanometer)
Subject will participate to only one session of measurement. The duration of one session is about 45 minutes.
Secondary Outcomes (1)
differences between the tested device and the gold standard (mercury sphygmomanometer according to the baseline blood pressure and to the wrist circumference
Subject will participate only one time to the study. one session of blood pressure measurement will be performed. the duration of one session is about 45 minutes
Study Arms (1)
one population of normotensive and hypertensive
OTHERtreated and untreated normotensive and hypertensive patients
Interventions
Measuring blood pressure using electronic device and using a mercury sphygmomanometer
Eligibility Criteria
You may qualify if:
- Patient older than 12 years;
- Patient who signed the informed consent form;
- Patient followed-up at site (in-patient or out-patient);
- Patient with wrist circumference between 12.5 and 21.5 cm\*. \*in accordance with the Indications For Use of the Combei BP 880 W device.
You may not qualify if:
- Patient unable to give a consent or understand properly protocol information;
- Patient suffering from arrhythmia;
- Patient with poor quality of Korotkov sounds;
- Patient for whom K5 sounds are absent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Roland Asmar
Paris, 75016, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
ROLAND ASMAR
International Society of Vascular Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor Roland Asmar
Study Record Dates
First Submitted
May 31, 2022
First Posted
June 1, 2023
Study Start
January 10, 2023
Primary Completion
May 23, 2023
Study Completion
May 27, 2023
Last Updated
June 1, 2023
Record last verified: 2023-05